Tirzepatide
GIP / GLP-1 · Weekly
A dual GIP and GLP-1 receptor agonist, given once a week, used in provider-supervised weight management programs.
- Form
- Vial · subcutaneous
- Frequency
- Once weekly
- Program
- Provider-supervised
Compounded medication. Compounded medications are not FDA-approved.
What it isand how it's used.
Tirzepatide acts on two hormone receptors, GIP and GLP-1, that play a role in appetite and blood sugar regulation. It is offered within a weight management program supervised by a licensed medical provider.
Given as a once-weekly injection under the skin, with the dose set and adjusted by your provider over time.
Good to know
Part of a complete program that includes nutrition and activity guidance.
Regular check-ins let your provider adjust your plan.
Compounded medications are not FDA-approved.
Your path to treatment
Choose your treatment
Pick a treatment and complete a short, private online intake from anywhere. It only takes a few minutes.
Provider review
A licensed medical provider reviews your history and goals, and may request labs or a virtual visit.
Delivered to your door
If treatment is appropriate, your prescription ships discreetly, with check-ins and refills as your plan evolves.
You may also consider.
Your best self,from home.
Start a private online intake in minutes. A licensed provider will review it and reach out with next steps.